Comparison of the effectiveness of cyclophosphamide and rituximab treatment in patients with systemic sclerosis-related interstitial lung diseases: a retrospective, observational cohort study

---

Yilmaz D. D., BÖREKÇİ Ş., MÜSELLİM B.

CLINICAL RHEUMATOLOGY, cilt.40, sa.10, ss.4071-4079, 2021 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 40 Sayı: 10
• Basım Tarihi: 2021
• Doi Numarası: 10.1007/s10067-021-05785-6
• Dergi Adı: CLINICAL RHEUMATOLOGY
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
• Sayfa Sayıları: ss.4071-4079
• Anahtar Kelimeler: Cyclophosphamide, Rituximab, Systemic sclerosis-related interstitial lung diseases
• İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

Objectives To compare the effectiveness of cyclophosphamide and rituximab in the treatment of patients with systemic sclerosis with pulmonary involvement (SSc-ILD).